ACTIVITY IN THE THIRD QUARTER OF 2017
(Unaudited data)
- CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2017
in thousands of euros | 2016 | 2017 | Variation at current exchange rates |
Variation at constant exchange rates |
France | 269,803 | 277,885 | +3.0% | +3.0% |
Europe (excluding France) | 116,530 | 110,158 | -5.5% | -8.0% |
North America | 46,197 | 48,699 | +5.4% | +5.0% |
Other countries | 11,187 | 11,849 | +5.9% | +2.5% |
Group total | 443,717 | 448,591 | +1.1% | +0.3% |
in thousands of euros | 2016 | 2017 | Variation at current exchange rates |
Variation at constant exchange rates |
Non-proprietary Homeopathic Medicines | 230,061 | 229,933 | -0.1% | -0.1% |
OTC Specialties | 212,781 | 217,701 | +2.3% | +0.7% |
Other | 875 | 957 | +9.4% | +9.3% |
Group total | 443,717 | 448,591 | +1.1% | +0.3% |
- DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
in thousands of euros | 1st quarter | 2nd quarter | 3rd quarter | ||||||
2016 | 2017 | Var. 17/16 | 2016 | 2017 | Var. 17/16 | 2016 | 2017 | Var. 17/16 | |
France | 90,494 | 97,134 | +7.3% | 80,469 | 79,328 | -1.4% | 98,840 | 101,423 | +2.6% |
Europe (excluding France) | 43,685 | 40,418 | -7.5% | 31,572 | 27,421 | -13.1% | 41,273 | 42,319 | +2.5% |
North America | 16,064 | 18,179 | +13.2% | 14,113 | 14,465 | +2.5% | 16,020 | 16,055 | +0.2% |
Other countries | 3,846 | 4,532 | +17.8% | 4,061 | 3,191 | -21.4% | 3,280 | 4,126 | +25.8% |
Group total | 154,089 | 160,263 | +4.0% | 130,215 | 124,405 | -4.5% | 159,413 | 163,923 | +2.8% |
in thousands of euros | 1st quarter | 2nd quarter | 3rd quarter | ||||||
2016 | 2017 | Var. 17/16 | 2016 | 2017 | Var. 17/16 | 2016 | 2017 | Var. 17/16 | |
Non-proprietary Homeopathic Medicines | 80,147 | 81,016 | +1.1% | 76,001 | 74,567 | -1.9% | 73,913 | 74,350 | +0.6% |
OTC Specialties | 73,743 | 78,968 | +7.1% | 53,719 | 49,391 | -8.1% | 85,319 | 89,342 | +4.7% |
Other | 199 | 279 | +40.2% | 495 | 447 | -9.7% | 181 | 231 | +27.6% |
Group total | 154,089 | 160,263 | +4.0% | 130,215 | 124,405 | -4.5% | 159,413 | 163,923 | +2.8% |
- HIGHLIGHTS OF THE THIRD QUARTER
- Sales revenue in the third quarter of 2017 is growing by 2.8% in comparison to 2016 (the impact of exchange rates is not significant over the period).
- Sales increase in particular in Russia, France and the Czech Republic. On the other hand, they decrease in Romania.
- OUTLOOK
The level of activity and profitability of the fiscal year will depend on the seasonal pathology of the fourth quarter.
Our company carries on the development of homeopathy in the world with the same determination.
Our next update:
January 25, 2018: at market close, publication of the sales revenue for the year 2017.
Person responsible for FINANCIAL information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information and the glossary are online at: www.boironfinance.com